Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49

ClinicalTrials.gov ID: NCT04142242

Public ClinicalTrials.gov record NCT04142242. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Immunogenicity of a Single Dose of MenACYW Conjugate Vaccine at Least 3 Years Following Initial Vaccination With Either Menomune® Vaccine or MenACYW Conjugate Vaccine in Older Adults

Study identification

NCT ID
NCT04142242
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Industry
Enrollment
471 participants

Conditions and interventions

Interventions

  • Meningococcal Polysaccharide (serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine Biological
  • Blood sample Other

Biological · Other

Eligibility (public fields only)

Age range
59 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 3, 2019
Primary completion
Mar 31, 2020
Completion
May 24, 2022
Last update posted
Sep 10, 2025

2019 – 2022

United States locations

U.S. sites
33
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
Investigational Site Number 8400026 Chandler Arizona 85225
Investigational Site Number 8400003 San Diego California 92123-1881
Investigational Site Number 8400028 Waterbury Connecticut 06708
Investigational Site Number 8400038 Clearwater Florida 33756
Investigational Site Number 8400023 DeLand Florida 32720
Investigational Site Number 8400007 Jacksonville Florida 32205
Investigational Site Number 8400015 Jacksonville Florida 32216
Investigational Site Number 8400022 Ponte Vedra Florida 32081
Investigational Site Number 8400032 Port Orange Florida 32127
Investigational Site Number 8400020 West Palm Beach Florida 33409
Investigational Site Number 8400027 Newton Kansas 67114
Investigational Site Number 8400017 Wichita Kansas 67205
Investigational Site Number 8400016 Metairie Louisiana 70006
Investigational Site Number 8400010 Elkridge Maryland 21075
Investigational Site Number 8400031 Richfield Minnesota 55423
Investigational Site Number 8400030 St Louis Missouri 63141
Investigational Site Number 8400019 Endwell New York 13760
Investigational Site Number 8400021 Greensboro North Carolina 27408
Investigational Site Number 8400012 Raleigh North Carolina 27612
Investigational Site Number 8400033 Winston-Salem North Carolina 27103
Investigational Site Number 8400013 Fargo North Dakota 58104
Investigational Site Number 8400035 Cincinnati Ohio 45241
Investigational Site Number 8400005 Cincinnati Ohio 45246
Investigational Site Number 8400011 Columbus Ohio 43212
Investigational Site Number 8400014 Uniontown Pennsylvania 15401
Investigational Site Number 8400018 Anderson South Carolina 29621
Investigational Site Number 8400034 Mt. Pleasant South Carolina 29464
Investigational Site Number 8400036 Mt. Pleasant South Carolina 29464
Investigational Site Number 8400024 Dallas Texas 75231
Investigational Site Number 8400001 Murray Utah 84123
Investigational Site Number 8400002 Salt Lake City Utah 84107
Investigational Site Number 8400025 West Jordan Utah 84088-8865
Investigational Site Number 8400004 Charlottesville Virginia 22911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04142242, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2025 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04142242 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →